πŸ‡ΊπŸ‡Έ FDA
Patent

US 9572828

Treatment for melanoma

granted A61KA61K31/4985A61K31/519

Quick answer

US patent 9572828 (Treatment for melanoma) held by The Board of Regents of the University of Texas System expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4985, A61K31/519, A61K31/7048, A61K38/2013